Clinical and radiologic features of BG germinomas
| Case No. | Age (yr) | Sex | Symptom Duration (mo) | Weakness of Limbs | Diabetes Insipidus | Increased ICP | Diagnosis | Tumor Marker (AFP, HCG) | Tumor Location | T1WI | T2WI | Contrast Enhancement | SWI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 14 | M | 2 | Y | N | N | HP | Neg | BG/TH | Slight hyper | Hyper | N | Hypo |
| 2 | 16 | M | 3 | Y | Y | N | HP | Neg | BG | Iso | Hyper | N | Hypo |
| 3 | 14 | M | 6 | Y | N | Y | HP | Neg | BG | Hetero/hyper | Hetero | Y (hetero) | Hetero/Hypo |
| 4 | 12 | M | 16 | Y | N | Y | HP | N/A | BG/TH | Hetero/hyper | Hetero | Y (hetero) | Hetero/Hypo |
| 5 | 13 | M | 8 | Y | Y | N | HP | Neg | BG/TH | Hetero | Hetero | Y (hetero) | Hetero/Hypo |
| 6 | 15 | M | 2 | Y | N | N | HP | Neg | BG | Iso | Hyper | N | Hypo |
Note:—Y indicates yes; N, no; ICP, intracranial pressure; HP, histologically proven; AFP, α-fetoprotein; HCG, human chorionic gonadotropin; N/A, not available; Neg, negative; BG, basal ganglia; TH, thalamus; Hetero, heterogeneous; Hyper, hyperintense; Hypo, hypointense; Iso, isointense; SWI, susceptibility-weighted imaging; T1WI, T1-weighted imaging; T2WI, T2-weighted imaging.